MORBIDITY AND MORTALITY IN FOLLICULAR THYROID-CANCER

被引:114
作者
DEGROOT, LJ
KAPLAN, EL
SHUKLA, NS
SALTI, G
STRAUS, FH
机构
[1] UNIV CHICAGO, DEPT SURG, CHICAGO, IL 60637 USA
[2] UNIV CHICAGO, DEPT PATHOL, CHICAGO, IL 60637 USA
关键词
D O I
10.1210/jc.80.10.2946
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The natural history and results of treatment have been analyzed in a group of 49 patients with follicular thyroid carcinoma who were followed for an average of 10.7 yr. Striking differences between the course of follicular thyroid carcinoma and the course of papillary carcinoma are evident. Deaths from cancer were double (16% for follicular), age at diagnosis was older, and age at death was younger. All deaths and recurrences happened within 13 yr, in contrast to the continued experience of deaths and recurrences in papillary cancer, even through 40 yr of observation. Adverse outcome correlated with extent of disease at diagnosis and with size of primary tumor, but did not correlate with vessel invasion, extent of capsule invasion, degree of dedifferentiation, extent of primary surgery, or radioactive iodide ablation. These observations are again in striking contrast to experience with papillary cancer. No patient with intrathyroidal disease who was under age 45 at diagnosis and with a primary tumor of less than 2.5 cm died. Our observations suggest that follicular cancer, even if apparently intrathyroidal, carries a high mortality rate in patients over,age 45 or in those with tumors larger than 2.5 cm at the time of diagnosis and suggest that we must consider additional therapeutic measures in this group of patients, including larger radioiodine doses for initial therapy, external radiotherapy, and even possibly prophylactic chemotherapy.
引用
收藏
页码:2946 / 2953
页数:8
相关论文
共 27 条
[1]  
BEENKEN S, 1989, ARCH OTOLARYNGOL, V115, P326
[2]   CHANGING CLINICAL, PATHOLOGIC, THERAPEUTIC, AND SURVIVAL PATTERNS IN DIFFERENTIATED THYROID-CARCINOMA [J].
CADY, B ;
SEDGWICK, CE ;
MEISSNER, WA ;
BOOKWALTER, JR ;
ROMAGOSA, V ;
WERBER, J .
ANNALS OF SURGERY, 1976, 184 (05) :541-553
[3]  
CADY B, 1988, SURGERY, V104, P947
[4]   THYROID-CANCER - THE CASE FOR TOTAL THYROIDECTOMY [J].
CLARK, OH ;
LEVIN, K ;
ZENG, QH ;
GREENSPAN, FS ;
SIPERSTEIN, A .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02) :305-313
[5]   NATURAL-HISTORY, TREATMENT, AND COURSE OF PAPILLARY THYROID-CARCINOMA [J].
DEGROOT, LJ ;
KAPLAN, EL ;
MCCORMICK, M ;
STRAUS, FH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02) :414-424
[6]   TREATMENT OF WELL-DIFFERENTIATED CARCINOMA OF THE THYROID BASED ON INITIAL STAGING [J].
DUFFIELD, RGM ;
LOWE, D ;
BURNAND, KG .
BRITISH JOURNAL OF SURGERY, 1982, 69 (07) :426-428
[7]  
FRANSSILA KO, 1973, CANCER-AM CANCER SOC, V32, P853, DOI 10.1002/1097-0142(197310)32:4<853::AID-CNCR2820320417>3.0.CO
[8]  
2-2
[9]   PROGNOSIS AND MORBIDITY AFTER TOTAL THYROIDECTOMY FOR PAPILLARY, FOLLICULAR AND MEDULLARY-THYROID CANCER [J].
HAMMING, JF ;
VANDEVELDE, CJH ;
GOSLINGS, BM ;
SCHELFHOUT, LJDM ;
FLEUREN, GJ ;
HERMANS, J ;
ZWAVELING, A .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (09) :1317-1323
[10]  
HAREL G, 1986, CANCER, V57, P1613, DOI 10.1002/1097-0142(19860415)57:8<1613::AID-CNCR2820570829>3.0.CO